On Monday, Moleculin Biotech Inc (NASDAQ: MBRX) was -10.18% drop from the session before settling in for the closing price of $3.83. A 52-week range for MBRX has been $3.63 – $91.25.
Healthcare Sector giant saw their annual sales surged by 26.36% over the last five years. When this article was written, the company’s average yearly earnings per share was at 77.00%. With a float of $2.02 million, this company’s outstanding shares have now reached $2.07 million.
Moleculin Biotech Inc (MBRX) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Moleculin Biotech Inc stocks. The insider ownership of Moleculin Biotech Inc is 2.13%, while institutional ownership is 1.51%. The most recent insider transaction that took place on Jun 23 ’25, was worth 100,000. In this transaction Chief Financial Officer of this company bought 270,270 shares at a rate of $0.37, taking the stock ownership to the 287,587 shares. Before that another transaction happened on Jun 23 ’25, when Company’s CEO and President bought 675,675 for $0.37, making the entire transaction worth $250,000. This insider now owns 743,607 shares in total.
Moleculin Biotech Inc (MBRX) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 77.00% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 70.85% during the next five years compared to 26.36% growth over the previous five years of trading.
Moleculin Biotech Inc (NASDAQ: MBRX) Trading Performance Indicators
You can see what Moleculin Biotech Inc (MBRX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 1.39.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -60.47, a number that is poised to hit -6.11 in the next quarter and is forecasted to reach -7.50 in one year’s time.
Technical Analysis of Moleculin Biotech Inc (MBRX)
Analysing the last 5-days average volume posted by the [Moleculin Biotech Inc, MBRX], we can find that recorded value of 0.2 million was lower than the volume posted last year of 0.21 million. As of the previous 9 days, the stock’s Stochastic %D was 13.04%.
During the past 100 days, Moleculin Biotech Inc’s (MBRX) raw stochastic average was set at 0.85%, which indicates a significant decrease from 2.87% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.54 in the past 14 days, which was lower than the 0.94 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.84, while its 200-day Moving Average is $15.24. Now, the first resistance to watch is $3.76. This is followed by the second major resistance level at $4.08. The third major resistance level sits at $4.30. If the price goes on to break the first support level at $3.22, it is likely to go to the next support level at $3.00. Now, if the price goes above the second support level, the third support stands at $2.68.
Moleculin Biotech Inc (NASDAQ: MBRX) Key Stats
There are 2,036K outstanding shares of the company, which has a market capitalization of 7.11 million. As of now, sales total 0 K while income totals -21,760 K. Its latest quarter income was 0 K while its last quarter net income were -25,400 K.
